will be a headwind in the near term. Equifax typically does not hedge its currency ..... top line.Compared to peer Experian, Equifax has taken a less value creative path in ..... advantage of international opportunities. Equifax 's businesses lines are characterized
Equifax (NYSE: EFX ) declares $0.25/share quarterly dividend , in line with previous. Forward yield 1.32% Payable Sept. 15; for shareholders of record Aug. 22; ex-div Aug. 20. Post your comment!
Equifax (NYSE: EFX ) Q2 2014 Earnings Call July 24, 2014 8:30 am ET Executives ..... Research Division Presentation Operator Good day, and welcome to the Q2 2014 Equifax Earnings Call. Today's conference is being recorded. At this time
Wide-moat-rated Equifax ’s second-quarter results contained no major surprises. Revenue was ..... performance was in line with the results we expect to see over time from Equifax , and we will maintain our fair value estimate and moat rating.
Equifax (NYSE: EFX ): Q2 EPS of $0.96 beats by $0.02 . Revenue of $613.9M (+4.6% Y/Y) misses by $2.13M . Press Release Post your comment!
Equifax ended the year on a solid note, but pointed to the headwinds it will face ..... a lower level. Outside of this segment, results were somewhat mixed. Equifax 's international operations performed well, posting an 11% increase excluding
Jan 16 (Reuters) - Equifax Inc : investcorp- investcorp announces the sale of tdx group to equifax for
Equifax announced that it will acquire TDX Group ..... customer bases and the connection between Equifax ’s credit bureau operations and debt collection ..... strategic rationale for the combination. While Equifax provided little data on TDX to judge the
Equifax 's third-quarter results show the company performing well across its segments. Total revenue increased 10% year over year
Woman sues Equifax , wins $18M Updated: Jul 29, 2013 8 ..... Oregon woman tried for two years to get Equifax to correct major errors in her credit ..... Miller's lawsuit says she contacted Equifax eight times about the mistakes. The judgment